Clinical trial
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have…
NCT00119626 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00119626 |
|---|---|
| Title | Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke |
| Official title | SAINT I (Stroke - Acute Ischemic - NXY Treatment) A Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter, Phase IIb/III Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cerebral Stroke, Ischemic Attack, Transient |
| Intervention type | Drug |
| Interventions | NXY-059 |
| Enrollment | 1,700 |
| Start date | Jun 1, 2003 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Jul 14, 2005 |
| Last update posted | Nov 15, 2010 |
| Countries | Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: